Eli Lilly (LLY) FCF Margin (2009 - 2026)

Eli Lilly (LLY) has reported FCF Margin for 18 consecutive years, with 15.19% the latest figure, recorded in Q1 2026.

• FCF Margin for Q1 2026 came in at 15.19%, up 1396.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.36% (up 874.0% YoY), and the FY2025 annual result was 13.77%, up 542.0% from the prior year.
• FCF Margin was 15.19% for Q1 2026 at Eli Lilly, up from 3.51% in the prior quarter.
• Over five years, FCF Margin peaked at 38.34% in Q3 2025 and troughed at 14.79% in Q4 2023.
• Average FCF Margin over 5 years is 11.2%, with a median of 12.52% recorded in 2022.
• Year-over-year, FCF Margin slumped 3070 bps in 2023 and soared 2201 bps in 2024.
• Over 5 years, FCF Margin stood at 15.91% in 2022, then tumbled by 193 bps to 14.79% in 2023, then surged by 149 bps to 7.22% in 2024, then slumped by 51 bps to 3.51% in 2025, then jumped by 332 bps to 15.19% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 15.19% in Q1 2026, 3.51% in Q4 2025, and 38.34% in Q3 2025.